Alpha Tau Medical (DRTS) Other Non-Current Liabilities (2020 - 2025)
Alpha Tau Medical (DRTS) reported Other Non-Current Liabilities of $5.4 million for Q4 2025, up 60.4% on a YoY basis from $3.3 million in Q4 2024, and up 60.4% sequentially from $3.3 million in Q4 2024.
Alpha Tau Medical (DRTS) Other Non-Current Liabilities (2020 - 2025) Analysis & Trends
Alpha Tau Medical (DRTS) has 6 years of Other Non-Current Liabilities data on file, last reported at $5.4 million in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Liabilities rose 60.4% year-over-year to $5.4 million; the trailing twelve-month figure through Dec 2025 stood at $5.4 million (up 60.4% YoY), and the FY2025 full-year result was $5.4 million, up 60.4% from the prior year.
- Other Non-Current Liabilities improved to $5.4 million in Q4 2025, from $3.3 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $18.6 million in Q4 2021 to a low of $977000.0 in Q4 2023.
- A 5-year average of $8.0 million and a median of $5.4 million in 2025 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities soared 247.06% in 2021 and plunged 88.04% in 2022, its largest moves.
- Tracing DRTS's Other Non-Current Liabilities over 5 years: stood at $18.6 million in 2021, then sank by 88.04% to $2.2 million in 2022, then sank by 56.15% to $977000.0 in 2023, then surged by 241.66% to $3.3 million in 2024, then surged by 60.4% to $5.4 million in 2025.
- Business Quant data shows DRTS's Other Non-Current Liabilities at $5.4 million in Q4 2025, $3.3 million in Q4 2024, and $977000.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alpha Tau Medical | 1.12 Bn | 1.04 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.35 Mn |
| Dec 31, 2024 | 3.34 Mn |
| Dec 31, 2023 | 977,000.00 |
| Dec 31, 2022 | 2.23 Mn |
| Mar 31, 2022 | 16.91 Mn |
| Dec 31, 2021 | 18.62 Mn |
| Mar 31, 2021 | 8.46 Mn |
| Dec 31, 2020 | 5.37 Mn |